Shengnan N. Zhao

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer.

Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer.

Journal: Chinese medical journal

Published: December 06, 2025

Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study.

Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study.

Journal: BMC medicine

Published: October 15, 2025

Effect of GnRH analogs in advanced male breast cancer: 10-year experience from the Henan Breast Cancer Center and literature review.

Effect of GnRH analogs in advanced male breast cancer: 10-year experience from the Henan Breast Cancer Center and literature review.

Journal: Chinese medical journal

Published: September 24, 2023

Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.

Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.

Journal: Nature communications

Published: February 19, 2023

Minimal lower eyelid epicanthoplasty combined with thermal contraction to treat epiblepharon in chinese children.

Minimal lower eyelid epicanthoplasty combined with thermal contraction to treat epiblepharon in chinese children.

Journal: BMC ophthalmology

Published: October 24, 2022

Diagnostic diversity and heterogeneity of tumors: a real-world study of metastasis re-biopsy in advanced breast cancer.

Diagnostic diversity and heterogeneity of tumors: a real-world study of metastasis re-biopsy in advanced breast cancer.

Journal: Chinese medical journal

Published: August 02, 2022

Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer

Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer

Journal: Zhonghua yi xue za zhi

Published: November 25, 2021

Efficacy and safety of bevacizumab-containing therapy for refractory advanced breast cancer: a retrospective study.

Efficacy and safety of bevacizumab-containing therapy for refractory advanced breast cancer: a retrospective study.

Journal: Annals of palliative medicine

Published: August 31, 2021

Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients.

Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients.

Journal: Annals of translational medicine

Published: June 16, 2021

Determination of oxalate and citrate in urine by capillary electrophoresis using solid-phase extraction and capacitively coupled contactless conductivity based on an improved mini-cell.

Determination of oxalate and citrate in urine by capillary electrophoresis using solid-phase extraction and capacitively coupled contactless conductivity based on an improved mini-cell.

Journal: Journal of separation science

Published: December 06, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026